327 related articles for article (PubMed ID: 33169199)
1. Classification of neuroendocrine neoplasms: lights and shadows.
La Rosa S; Uccella S
Rev Endocr Metab Disord; 2021 Sep; 22(3):527-538. PubMed ID: 33169199
[TBL] [Abstract][Full Text] [Related]
2. The classification of neuroendocrine neoplasms of the breast and its clinical relevance.
Uccella S
Virchows Arch; 2022 Jul; 481(1):3-12. PubMed ID: 34698887
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis and classification.
Uccella S; Ottini G; Facco C; Maragliano R; Asioli S; Sessa F; La Rosa S
Pathologica; 2017 Mar; 109(1):14-30. PubMed ID: 28635990
[TBL] [Abstract][Full Text] [Related]
4. Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms.
La Rosa S
Endocr Pathol; 2021 Jun; 32(2):245-257. PubMed ID: 33786701
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
Uccella S; La Rosa S; Volante M; Papotti M
Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
[TBL] [Abstract][Full Text] [Related]
6. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
Scoazec JY
Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
[TBL] [Abstract][Full Text] [Related]
7. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.
Rindi G; Klimstra DS; Abedi-Ardekani B; Asa SL; Bosman FT; Brambilla E; Busam KJ; de Krijger RR; Dietel M; El-Naggar AK; Fernandez-Cuesta L; Klöppel G; McCluggage WG; Moch H; Ohgaki H; Rakha EA; Reed NS; Rous BA; Sasano H; Scarpa A; Scoazec JY; Travis WD; Tallini G; Trouillas J; van Krieken JH; Cree IA
Mod Pathol; 2018 Dec; 31(12):1770-1786. PubMed ID: 30140036
[TBL] [Abstract][Full Text] [Related]
8. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
9. Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.
La Rosa S; Sessa F; Uccella S
Endocr Pathol; 2016 Dec; 27(4):284-311. PubMed ID: 27169712
[TBL] [Abstract][Full Text] [Related]
10. The classification of neuroendocrine neoplasms of the lung and digestive system according to WHO, 5th edition: similarities, differences, challenges, and unmet needs.
Sanguedolce F; Zanelli M; Palicelli A; Cavazza A; DE Marco L; Zizzo M; Ascani S; Landriscina M; Giordano G; Sollitto F; Loizzi D
Panminerva Med; 2022 Jun; 64(2):259-264. PubMed ID: 35146989
[TBL] [Abstract][Full Text] [Related]
11. Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast.
Yang L; Roy M; Lin H; Shen Y; Albarracin C; Huo L; Chen H; Wei B; Bedrosian I; Bu H; Wu Y
Breast Cancer Res Treat; 2021 Apr; 186(2):403-415. PubMed ID: 33528758
[TBL] [Abstract][Full Text] [Related]
12. Morphologic and molecular classification of lung neuroendocrine neoplasms.
Metovic J; Barella M; Bianchi F; Hofman P; Hofman V; Remmelink M; Kern I; Carvalho L; Pattini L; Sonzogni A; Veronesi G; Harari S; Forest F; Papotti M; Pelosi G
Virchows Arch; 2021 Jan; 478(1):5-19. PubMed ID: 33474631
[TBL] [Abstract][Full Text] [Related]
13. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Yin F; Wu ZH; Lai JP
World J Gastroenterol; 2022 May; 28(17):1751-1767. PubMed ID: 35633912
[TBL] [Abstract][Full Text] [Related]
14. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
[TBL] [Abstract][Full Text] [Related]
15. Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.
Singhi AD; Klimstra DS
Histopathology; 2018 Jan; 72(1):168-177. PubMed ID: 29239037
[TBL] [Abstract][Full Text] [Related]
16. An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs.
Couvelard A; Cros J
Virchows Arch; 2022 Jun; 480(6):1129-1148. PubMed ID: 35278097
[TBL] [Abstract][Full Text] [Related]
17. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].
Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
Klöppel G
Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of new classification of gastroenteropancreatic neuroendocrine neoplasms].
Zhu XZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):12-4. PubMed ID: 23691561
[TBL] [Abstract][Full Text] [Related]
20. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review.
Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F
Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
